Capecitabine in combination with oxaliplatin as first line therapy for patients (pts) with advanced or metastatic colorectal cancer (ACRC): preliminary results of an international multicenter phase II study
暂无分享,去创建一个
T. Conroy | J. Tabernero | A. Figer | C. Twelves | J. Cassidy | P. Schöffski | C. Butts | F. Debraud | E. Díaz-Rubio | A. Sobrero | E. Cutsem | J. Grossmann